In 2023, the Canadian government dedicated $19 million to the Public Health Agency of Canada for economic incentives to propel antimicrobial projects. It's a three-year project aimed at improving access to two priority antimicrobials that are not currently available in Canada, but developed by international pharmaceutical companies.
Since AMR is a global issue, how important is it for the countries to work together?